Reproducibility of the serum lipid response to coffee oil in healthy volunteers

Nutrition Journal

Volumn 2, Issue , 2003, Pages 1-8

  Boekschoten, Mark V ^a   Engberink, Mariëlle F ^a   Katan, Martijn B ^a   Schouten, Evert G ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CAFESTOL; COFFEE OIL; EDIBLE OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; KAHWEOL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; COFFEE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; REPRODUCIBILITY; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALIA;

EID: 3042553342     PISSN: 14752891     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2891-2-8     Document Type: Article

References (25)

1. Beynen AC and Katan MB: Reproducibility of the variations between humans in the response of serum cholesterol to cessation of egg consumption. Atherosclerosis 1985, 57(1):19-31.
2. Katan MB, Beynen AC, De Vries JH and Nobels A: Existence of consistent hypo- and hyperresponders to dietary cholesterol in man. Am J Epidemiol 1986, 123(2):221-34.
3. Katan MB and Beynen AC: Characteristics of human hypo- and hyperresponders to dietary cholesterol. Am J Epidemiol 1987, 125(3):387-99.
4. Beynen AC, Katan MB and Van Zutphen LF: Hypo- and hyperresponders: individual differences in the response of serum cholesterol concentrations to changes in diet. Adv Lipid Res 1987, 22:115-71.
5. Katan MB, Van Gastel AC, De Rover CM, Van Montfort MA and Knuiman JT: Differences in individual responsiveness of serum cholesterol to fat-modified diets in man. Eur J Clin Invest 1988, 18(6):644-7.
6. Ordovas JM, Lopez-Miranda J, Mata P, Perez-Jimenez F, Lichtenstein AH and Schaefer EJ: Gene-diet interactions in determining plasma lipid response to dietary intervention. Atherosclerosis 1995, Suppl 1 18:S11-S27.
7. Ordovas JM and Schaefer EJ: Genes, variation of cholesterol and fat intake and serum lipids. Curr Opin Lipidol 1999, 10:15-22.
8. Clifton PM and Abbey M: Genetic control of response to dietary fat and cholesterol. World Rev Nutr Diet 1997, 80:1-14.
9. Weusten-van der Wouw MP, Katan MB, Viani R, Huggett AC, Liardon R and Liardon R: Identity of the cholesterol-raising factor from boiled coffee and its effects on liver function enzymes. J Lipid Res 1994, 35:721-33.
10. Urgert R, Van der Weg G, Kosmeijer-Schuil TG, Van den Bovenkamp P and Hovenier R: Levels of the cholesterol-elevating diterpenes cafestol and kahweol in various coffee brews. J Agric Food Chem 1995, 43:2167-72.
11. Urgert R and Katan MB: The cholesterol-raising factor from coffee beans. Annu Rev Nutr 1997, 17:305-24.
12. Urgert R, Essed N, Van der Weg G, Kosmeijer-Schuil TG and Katan MB: Separate effects of the coffee diterpenes cafestol and kahweol on serum lipids and liver aminotransferases. Am J Clin Nutr 1997, 65(2):519-24.
13. Friedewald WT, Levy RI and Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18(6):499-502.
14. de Roos B, Caslake MJ, Stalenhoef AF, Bedford D, Demacker PN, Katan MB and Packard CJ: The coffee diterpene cafestol increases plasma triacylglycerol by increasing the production rate of large VLDL apolipoprotein B in healthy normolipidemic subjects. Am J Clin Nutr 2001, 73(1):45-52.
15. Cooper GR, Myers GL, Smith SJ and Sampson EJ: Standardization of lipid, lipoprotein and apolipoprotein measurements. Clin Chem 1988, 34(8B):B95-105.
16. Cooper GR, Myers GL, Smith SJ and Schlant RC: Blood lipid measurements: Variations and practical utility. JAMA 1992, 267(12):1652-60.
17. Urgert R, Schulz AG and Katan MB: Effects of cafestol and kahweol from coffee grounds on serum lipids and serum liver enzymes in humans. Am J Clin Nutr 1995, 61(1):149-54.
18. Keil R: Determination of enzyme activities in serum for the detection of xenobiotic effects on the liver. Exp Pathol 1990, 39:157-64.
19. Herrera JL: Abnormal liver enzyme levels. The spectrum of causes. Postgrad Med 1993, 93(2):113-6.
20. Sherman KE: Alanine amintransferase in clinical practice. A review. Arch Intern Med 1991, 151(2):260-5.
21. Weggemans RM, Zock PL, Ordovas JM, Ramos-Galluzi J and Katan MB: Genetic polymorphisms and lipid response to dietary changes in humans. Eur J Clin Invest 2001, 31(11):950-957.
22. Princen HM, Post SM and Twisk J: Regulation of bile acid synthesis. Curr Pharmaceut Design 1997, 3(1):59-84.
23. Tu H, Okamoto AY and Shan B: FXR, a bile acid receptor and biological sensor. Trends Cardiovasc Med 2000, 10(1):30-5.
24. Chawla A, Repa JJ, Evans RM and Mangseldorf DJ: Nuclear receptors and lipid physiology: Opening the X-files. Science 2001, 294(5548):1866-70.
25. Post SM, de Roos B, Vermeulen M, Afman L, Jong MC and Dahlmans VE: Cafestol increases serum cholesterol levels in apolipoprotein E*3-Leiden transgenic mice by suppression of bile acid synthesis. Arterioscler Thromb Vasc Biol 2000, 20(6):1551-6.